Scott Eggener

3.1K posts

Scott Eggener banner
Scott Eggener

Scott Eggener

@uroegg

Truth and science matter. Support both. Professor and Chair of Urology - UCLA

Los Angeles Katılım Şubat 2013
402 Takip Edilen6.4K Takipçiler
Scott Eggener retweetledi
Matt Cooperberg
Matt Cooperberg@dr_coops·
Prof Hugosson: Göteborg trial with 30 year outcomes! NND falls to -6-, with greatest benefit for men 50-59 at randomization. Despite no image guidance, high overdx, and suboptimal tx. Best evidence we have re: the evidence for #prostatecancer screening. Get tested! #eau26 @uroweb
Matt Cooperberg tweet mediaMatt Cooperberg tweet mediaMatt Cooperberg tweet mediaMatt Cooperberg tweet media
English
0
39
98
5.8K
Scott Eggener
Scott Eggener@uroegg·
@DrSpratticus Valuable comments @Spratticus Often, not always, less is more Myriad reasons those studies aren’t routinely done Come join those of us who have tried contributing data to this essential conversation
English
0
0
6
562
Daniel E Spratt
Daniel E Spratt@DrSpratticus·
#GU26 and #fengsymposium was a blast to see progress. Hoping it eventually moves away from San Fran 😁. Another red eye on the books back home. My observations from PCa sessions: - the field continues to push for over tx and many fail to recognize high risk dz is not high risk anymore for most patients. Enzarad negative, Rtog 0924 neg, ascend-RT neg for MFS/OS, peace2 neg. RT+ADT plenty for most. Many need even less. Select trials paving the way. - for mHSPC not all patients need doublet let alone triplet; age matters - continuous ADT can often be more harmful than helpful now with MDT -most BCR patients post RP do not need ADT—> get biomarker testing to help -many have jumped on bandwagon that OS too hard to improve and settling for early non-surrogate endpoints; peace3 should remind us it’s possible -sequential PARPi /Abi often just as good as combination -early germline/somatic testing for all high risk disease remains without data to support it; even testing in mHSPC unclear benefit as can give PARPi in mCRPC setting (earlier not better than later). -actinium RLT promising but toxicity remains concern -neoadj before RP remains largely ineffective, adds costs and toxicity and most still need postop tx.
English
8
32
98
12.1K
Scott Eggener
Scott Eggener@uroegg·
Interested in catapulting your career in a 1 year fellowship with world-class urologists and an emphasis on innovative imaging, diagnostic, and focal PrCa treatments? Availability July 2026
Scott Eggener tweet media
English
5
7
45
4.9K
Scott Eggener retweetledi
UCLA Urology
UCLA Urology@UclaUrology·
Happy #matchday soon to be Urologists Congrats to soon-to-be-doctors Bettencourt, Lerman, Borrell, and Yoffe We look forward to welcoming you to the @UCLAHealth Urology family this summer. For those who didn't receive the news they hoped for, your journey is still beginning.
UCLA Urology tweet media
English
2
12
97
17.3K
Scott Eggener retweetledi
UCLA Urology
UCLA Urology@UclaUrology·
Our annual state of the art is just around the corner. Whether you are an alumni, colleague practicing nearby, or traveling for your CME we hope you join us for this immersive course. There is content for all. Info and registration below web.cvent.com/event/159d0f39…
UCLA Urology tweet media
English
0
2
7
4.2K
Scott Eggener
Scott Eggener@uroegg·
Correction: these were both listed on JAMA Surgery Most Viewed of 2025
English
0
0
4
1.1K
Scott Eggener
Scott Eggener@uroegg·
Fascinatingly counterintuitive If observation is indeed true, many potential explanations (P.S. article in same issue shows surgeon mortality is higher than non-surgeon physicians) Association Between Surgeon Stress and Major Surgical Complications jamanetwork.com/journals/jamas…
English
3
4
26
3.6K
Scott Eggener
Scott Eggener@uroegg·
Always used hemostatic agents for PNx, then used for 50% of cases during the trial, now will only use very selectively.....lots of gratitude to the team and patients who made this happen auajournals.org/doi/10.1097/JU…
English
7
8
59
6.1K
Scott Eggener
Scott Eggener@uroegg·
It's that time of year.....if you dig high quality urology speakers, world-class skiing, and memorable camaraderie, consider Aspen Urological Conference Feb 9-12 aspenuro.org
English
1
1
16
2.6K
Scott Eggener
Scott Eggener@uroegg·
Remains one of the cheapest/easiest ways to minimize unnecessary testing, biopsy, diagnosis, or treatment: repeat a newly elevated PSA (without empiric abx) jamanetwork.com/journals/jamao…
English
4
13
84
13.4K